In a letter dated October 7, the Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi emphasised the "critical importance of testing new materials, including the excipients, before their use in the manufacturing of pharmaceutical formulations."
According to the release, the two-day event in Delhi saw the presence of Dr Rajiv Bahl, Secretary of the Department of Health Research (DHR) and DG, ICMR, and Dr Rajeev Singh Raghuvanshi, Drug Controller General of India.
Dr PBN Prasad will hold the charge of the post of Drug Controller of India from February 16 to 28 this year or until further orders, an official notice said on Wednesday.
The Union Public Service Commission (UPSC) has recommended the name of Dr Rajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).